PL2268157T3 - Mieszanina tryptofanu związanego z peptydem i tryptofanu związanego z polipeptydem - Google Patents
Mieszanina tryptofanu związanego z peptydem i tryptofanu związanego z polipeptydemInfo
- Publication number
- PL2268157T3 PL2268157T3 PL09738099T PL09738099T PL2268157T3 PL 2268157 T3 PL2268157 T3 PL 2268157T3 PL 09738099 T PL09738099 T PL 09738099T PL 09738099 T PL09738099 T PL 09738099T PL 2268157 T3 PL2268157 T3 PL 2268157T3
- Authority
- PL
- Poland
- Prior art keywords
- bound tryptophan
- polypeptide
- peptide
- mixture
- tryptophan
- Prior art date
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/08—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from eggs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08155315 | 2008-04-29 | ||
| PCT/EP2009/055038 WO2009133055A1 (en) | 2008-04-29 | 2009-04-27 | Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
| EP09738099.2A EP2268157B1 (en) | 2008-04-29 | 2009-04-27 | Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2268157T3 true PL2268157T3 (pl) | 2015-12-31 |
Family
ID=39811461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09738099T PL2268157T3 (pl) | 2008-04-29 | 2009-04-27 | Mieszanina tryptofanu związanego z peptydem i tryptofanu związanego z polipeptydem |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8802088B2 (pl) |
| EP (1) | EP2268157B1 (pl) |
| JP (1) | JP5626807B2 (pl) |
| KR (1) | KR101698216B1 (pl) |
| CN (1) | CN102076228B (pl) |
| BR (1) | BRPI0911907B8 (pl) |
| EA (2) | EA029869B1 (pl) |
| ES (1) | ES2550463T3 (pl) |
| PL (1) | PL2268157T3 (pl) |
| WO (1) | WO2009133055A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2079847B1 (en) | 2006-11-02 | 2012-03-07 | DSM IP Assets B.V. | Use of lysozyme hydrolysates containing tryptophan |
| JP5493195B2 (ja) * | 2008-04-29 | 2014-05-14 | ディーエスエム アイピー アセッツ ビー.ブイ. | 炭水化物およびトリプトファン含有ペプチドを含む組成物 |
| KR101698216B1 (ko) * | 2008-04-29 | 2017-01-19 | 디에스엠 아이피 어셋츠 비.브이. | 펩타이드-결합된 트립토판과 폴리펩타이드-결합된 트립토판의 혼합물 |
| CN103153326B (zh) | 2010-10-05 | 2015-08-19 | 帝斯曼知识产权资产管理有限公司 | 含有色氨酸的肽 |
| WO2012146651A1 (en) | 2011-04-28 | 2012-11-01 | Dsm Ip Assets B.V. | Protein hydrolysates as agents for overcoming addiction |
| US10194674B2 (en) | 2011-09-01 | 2019-02-05 | John C. Gilkey | Nutritional compositions |
| JP2013159591A (ja) * | 2012-02-08 | 2013-08-19 | Morinaga Milk Ind Co Ltd | 多動性抑制剤 |
| ES2670942T3 (es) * | 2012-11-02 | 2018-06-04 | Dsm Ip Assets B.V. | Uso de hidrolizados proteicos ricos en triptófano |
| CN105828829A (zh) | 2013-12-18 | 2016-08-03 | 帝斯曼知识产权资产管理有限公司 | 用于含角蛋白的组织的包含溶菌酶水解物的组合物 |
| AU2016317046B2 (en) * | 2015-08-31 | 2022-03-10 | Nutramax Laboratories, Inc. | Compositions comprising magnolia, phellodendron, theanine and/or whey protein |
| US10591221B1 (en) | 2017-04-04 | 2020-03-17 | Mainstream Engineering Corporation | Advanced cooling system using throttled internal cooling passage flow for a window assembly, and methods of fabrication and use thereof |
| JP7139727B2 (ja) * | 2018-06-29 | 2022-09-21 | キリンホールディングス株式会社 | 運動制御機能および運動学習機能向上用組成物 |
| NL2022627B1 (en) * | 2019-02-22 | 2020-08-31 | Newtricious Bv | Lysozyme hydrolysate for proactive inhibitory control and for attention |
| JP7428480B2 (ja) * | 2019-06-06 | 2024-02-06 | 雪印メグミルク株式会社 | 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料 |
| CA3212435A1 (en) * | 2021-03-15 | 2022-09-22 | Lara Nyman | Nutritional composition for improving sleep |
| CN120957737A (zh) * | 2023-03-29 | 2025-11-14 | 株式会社明治 | 多巴胺释放量增强剂、运动控制功能改善剂、运动学习功能改善剂以及活动欲望改善剂 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02279700A (ja) * | 1989-04-19 | 1990-11-15 | Asahi Chem Ind Co Ltd | 高トリプトファン含有ペプチド |
| FR2657013B1 (fr) * | 1990-01-18 | 1992-05-15 | Medgenix Group Sa | Composition dietetique a base de polypeptides et acides amines. |
| ATE357454T1 (de) * | 2000-12-06 | 2007-04-15 | Campina Nederland Holding Bv | Verfahren zur herstellung tryptophanreicher peptide |
| JP4221231B2 (ja) * | 2002-02-28 | 2009-02-12 | 株式会社ファーマフーズ | 抗菌組成物、その製造方法及び該抗菌組成物を含有する抗菌剤 |
| TW200603790A (en) * | 2004-04-19 | 2006-02-01 | Kirin Brewery | Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| CN101022737B (zh) | 2004-07-22 | 2012-08-15 | 格罗伯斯卵类科学有限公司 | 抗高血压的功能性食品 |
| EP1685764A1 (en) | 2005-01-27 | 2006-08-02 | Globus Egg Sciences B.V. | Anti-hypertensive functional food products |
| US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| EP2079847B1 (en) * | 2006-11-02 | 2012-03-07 | DSM IP Assets B.V. | Use of lysozyme hydrolysates containing tryptophan |
| JP5493195B2 (ja) * | 2008-04-29 | 2014-05-14 | ディーエスエム アイピー アセッツ ビー.ブイ. | 炭水化物およびトリプトファン含有ペプチドを含む組成物 |
| KR101698216B1 (ko) | 2008-04-29 | 2017-01-19 | 디에스엠 아이피 어셋츠 비.브이. | 펩타이드-결합된 트립토판과 폴리펩타이드-결합된 트립토판의 혼합물 |
-
2009
- 2009-04-27 KR KR1020107026520A patent/KR101698216B1/ko active Active
- 2009-04-27 ES ES09738099.2T patent/ES2550463T3/es active Active
- 2009-04-27 EA EA201400526A patent/EA029869B1/ru not_active IP Right Cessation
- 2009-04-27 EP EP09738099.2A patent/EP2268157B1/en active Active
- 2009-04-27 PL PL09738099T patent/PL2268157T3/pl unknown
- 2009-04-27 US US12/989,869 patent/US8802088B2/en active Active
- 2009-04-27 EA EA201001711A patent/EA021506B1/ru not_active IP Right Cessation
- 2009-04-27 CN CN200980125142.8A patent/CN102076228B/zh active Active
- 2009-04-27 JP JP2011506670A patent/JP5626807B2/ja active Active
- 2009-04-27 BR BRPI0911907A patent/BRPI0911907B8/pt active IP Right Grant
- 2009-04-27 WO PCT/EP2009/055038 patent/WO2009133055A1/en not_active Ceased
-
2014
- 2014-07-10 US US14/327,683 patent/US9770493B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101698216B1 (ko) | 2017-01-19 |
| BRPI0911907B8 (pt) | 2021-05-25 |
| EA021506B1 (ru) | 2015-07-30 |
| US9770493B2 (en) | 2017-09-26 |
| EP2268157B1 (en) | 2015-08-19 |
| US20150037313A1 (en) | 2015-02-05 |
| EA201400526A1 (ru) | 2014-12-30 |
| JP5626807B2 (ja) | 2014-11-19 |
| US20110110919A1 (en) | 2011-05-12 |
| WO2009133055A1 (en) | 2009-11-05 |
| KR20100135319A (ko) | 2010-12-24 |
| JP2011523547A (ja) | 2011-08-18 |
| CN102076228B (zh) | 2016-08-03 |
| EA029869B1 (ru) | 2018-05-31 |
| US8802088B2 (en) | 2014-08-12 |
| BRPI0911907B1 (pt) | 2021-02-02 |
| BRPI0911907A2 (pt) | 2015-07-28 |
| EA201001711A1 (ru) | 2011-06-30 |
| CN102076228A (zh) | 2011-05-25 |
| ES2550463T3 (es) | 2015-11-10 |
| EP2268157A1 (en) | 2011-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2268157T3 (pl) | Mieszanina tryptofanu związanego z peptydem i tryptofanu związanego z polipeptydem | |
| EG27167A (en) | Microemulsifiers and methods of making and using same | |
| IL209754A0 (en) | Diazacarbazoles and methods of use | |
| IL213547A0 (en) | Compounds and methods of use | |
| SG10201400162QA (en) | Tgr5 modulators and methods of use thereof | |
| ZA201102076B (en) | Herbicide-resistant ahas-mutants and methods of use | |
| IL205977A0 (en) | 5-anilinoimidazopyridines and methods of use | |
| EP2334185A4 (en) | COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL | |
| EP2126087A4 (en) | METHODS FOR PRODUCING PHARMACOTHEQUES, AND USES THEREOF | |
| GB0809278D0 (en) | Scooter and method of use thereof | |
| IL234954B (en) | Antibodies 1a–il and methods of use | |
| IL206225A0 (en) | Compositions and methods of detecting tiabs | |
| EP2299931A4 (en) | CLOSURE DEVICE AND METHODS OF USE THEREOF | |
| LT2373691T (lt) | Anti-fxi antikūnai ir jų panaudojimo būdai | |
| IL206583A0 (en) | Airway assembly and methods of using an airway assembly | |
| IL211623A0 (en) | Anti-notch2 antibodies and methods of use | |
| IL209548A0 (en) | Diazacarbazoles and methods of use | |
| IL206125A0 (en) | Azaindolizines and methods of use | |
| GB0700372D0 (en) | Device and methods of using device | |
| IL226244A (en) | Methods for the synthesis of amine thiazolopyridine-2-ylaoxy-phenyl and thiazolopyrazine-2-ylaoxy-phenyl | |
| EP2142926A4 (en) | COMPOSITIONS AND METHODS OF DETECTION | |
| IL207827A0 (en) | Apoaequorin-containing compositions and methods of using same | |
| ZA201007681B (en) | Cd4-related polypeptides and methods of use | |
| IL209545A0 (en) | Substotited pyrroles and methods of use | |
| AU326460S (en) | Bowl and stand |